BRIEF-Twist Bioscience Enters Into Royalty Purchase Agreement With Xoma Royalty For $15 Million In Cash

Reuters10-22

Oct 22 (Reuters) - Twist Bioscience Corp :

* TWIST BIOSCIENCE ENTERS INTO ROYALTY PURCHASE AGREEMENT WITH XOMA ROYALTY FOR $15 MILLION IN CASH

* TWIST BIOSCIENCE CORP - XOMA TO PAY $15 MILLION FOR HALF OF FUTURE MILESTONES AND ROYALTIES

* TWIST BIOSCIENCE CORP - TO RETAIN ALL UPFRONT, SERVICE AND OTHER REVENUE

* TWIST BIOSCIENCE CORP - RETAINS FULL RIGHTS TO FUTURE BIOPHARMA COLLABORATIONS

* TWIST BIOSCIENCE CORP - AGREEMENT EXCLUDES SYNBIO, NGS, AND DATA STORAGE REVENUE

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2477396993?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-22 20:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477396993","market":"us","top_or_hot":-1,"title":"BRIEF-Twist Bioscience Enters Into Royalty Purchase Agreement With Xoma Royalty For $15 Million In Cash","media":"Reuters","content":"<html><body><p>Oct 22 (Reuters) - <a href=\"https://laohu8.com/S/TWST\">Twist Bioscience Corp</a>   :</p><p>   * TWIST BIOSCIENCE ENTERS INTO ROYALTY PURCHASE AGREEMENT WITH XOMA ROYALTY FOR $15 MILLION IN CASH</p><p>   * TWIST BIOSCIENCE CORP - XOMA TO PAY $15 MILLION FOR HALF OF <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a> MILESTONES AND ROYALTIES</p><p>   * TWIST BIOSCIENCE CORP - TO RETAIN ALL UPFRONT, SERVICE AND OTHER REVENUE</p><p>   * TWIST BIOSCIENCE CORP - RETAINS FULL RIGHTS TO FUTURE BIOPHARMA COLLABORATIONS</p><p>   * TWIST BIOSCIENCE CORP - AGREEMENT EXCLUDES SYNBIO, NGS, AND DATA STORAGE REVENUE</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Twist Bioscience Enters Into Royalty Purchase Agreement With Xoma Royalty For $15 Million In Cash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Twist Bioscience Enters Into Royalty Purchase Agreement With Xoma Royalty For $15 Million In Cash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-22 20:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oct 22 (Reuters) - Twist Bioscience Corp   :   * TWIST BIOSCIENCE ENTERS INTO ROYALTY PURCHASE AGREEMENT WITH XOMA ROYALTY FOR $15 MILLION IN CASH   * TWIST BIOSCIENCE CORP - XOMA TO PAY $15 MILLION ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2477396993","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477396993","pubTimestamp":1729601420,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Oct 22  - Twist Bioscience Corp   :   * TWIST BIOSCIENCE ENTERS INTO ROYALTY PURCHASE AGREEMENT WITH XOMA ROYALTY FOR $15 MILLION IN CASH   * TWIST BIOSCIENCE CORP - XOMA TO PAY $15 MILLION FOR HALF OF FUTURE MILESTONES AND ROYALTIES   * TWIST BIOSCIENCE CORP - TO RETAIN ALL UPFRONT, SERVICE AND OTHER REVENUE   * TWIST BIOSCIENCE CORP - RETAINS FULL RIGHTS TO FUTURE BIOPHARMA COLLABORATIONS   * TWIST BIOSCIENCE CORP - AGREEMENT EXCLUDES SYNBIO, NGS, AND DATA STORAGE REVENUESource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","TWST":"Twist Bioscience Corp","BK4139":"生物科技"},"translate_title":"BRIEF-Twist Bioscience以1500万美元现金与Xoma Royalty签订特许权使用费购买协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":0.9},"content_text":"Oct 22 (Reuters) - Twist Bioscience Corp   :   * TWIST BIOSCIENCE ENTERS INTO ROYALTY PURCHASE AGREEMENT WITH XOMA ROYALTY FOR $15 MILLION IN CASH   * TWIST BIOSCIENCE CORP - XOMA TO PAY $15 MILLION FOR HALF OF FUTURE MILESTONES AND ROYALTIES   * TWIST BIOSCIENCE CORP - TO RETAIN ALL UPFRONT, SERVICE AND OTHER REVENUE   * TWIST BIOSCIENCE CORP - RETAINS FULL RIGHTS TO FUTURE BIOPHARMA COLLABORATIONS   * TWIST BIOSCIENCE CORP - AGREEMENT EXCLUDES SYNBIO, NGS, AND DATA STORAGE REVENUESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477396993"}